Literature DB >> 8309312

Rapamycin: a novel immunosuppressive macrolide.

S N Sehgal1, K Molnar-Kimber, T D Ocain, B M Weichman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8309312     DOI: 10.1002/med.2610140102

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  29 in total

Review 1.  Nontraditional microbial bioactive metabolites.

Authors:  V Bĕhal
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

Review 2.  New immunosuppressive drugs and lung transplantation: last or least?

Authors:  J W van den Berg; D S Postma; G H Koëter; W van der Bij
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

3.  Case report: Corticosteroid-resistant nephrotic syndrome: treatment with rapamune.

Authors:  Liern Jose Miguel; Graciela V Vallejo
Journal:  Pediatr Nephrol       Date:  2006-09-15       Impact factor: 3.714

4.  CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling.

Authors:  Xiaolin Wan; Na Shen; Arnulfo Mendoza; Chand Khanna; Lee J Helman
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

5.  Methionine interference in rapamycin production involves repression of demethylrapamycin methyltransferase and S-adenosylmethionine synthetase.

Authors:  W S Kim; Y Wang; A Fang; A L Demain
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 6.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 7.  mTOR inhibitors in advanced renal cell carcinoma.

Authors:  Martin H Voss; Ana M Molina; Robert J Motzer
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

8.  Phosphate, ammonium, magnesium and iron nutrition of Streptomyces hygroscopicus with respect to rapamycin biosynthesis.

Authors:  Y R Cheng; L Hauck; A L Demain
Journal:  J Ind Microbiol       Date:  1995-05

Review 9.  Everolimus and sirolimus in transplantation-related but different.

Authors:  Jost Klawitter; Björn Nashan; Uwe Christians
Journal:  Expert Opin Drug Saf       Date:  2015-04-26       Impact factor: 4.250

Review 10.  Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies.

Authors:  Jorge A Garcia; David Danielpour
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.